Oculis’ Post

View organization page for Oculis, graphic

3,960 followers

Yesterday we announced the appointment of Snehal Shah, Pharm. D. as President of Research & Development. Dr. Shah’s joins Oculis from Iveric Bio and brings extensive experience in drug development, regulatory affairs and ophthalmology, with over a dozen successful market approvals.   His extensive strategic experience in leading R&D and regulatory functions, and successful track record will play a pivotal role in our efforts to deliver transformative new therapies to patients suffering from eye diseases.   For additional details, including important information on forward-looking statements, see our press release here: https://bit.ly/3JdxhDS   #eyehealth #ophthalmology #biotech #biopharma #leadership #healthcare

  • No alternative text description for this image
Judy Doll

Clinical Quality Assurance Leader. Open to consulting and full-time employment

5mo

Congratulations on you new appointment, very well deserved. Wishing you all the best.

Like
Reply
Joel Lippman

Chief Operating Officer at Noven Pharmaceuticals

6mo

Congratulations Sne, that is really great and I knew you when…..

Sne, congratulations on your new position! Much success !

Like
Reply
Clara Song, PharmD, MBA

Director, Medical Information, Medical/Promotional Review Committee

6mo

Congrats Sne!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics